Loading company…
Solu researches tools and drugs to detect and prevent antibiotic resistance.
Solu Healthcare researches and develops methods to detect and prevent antibiotic resistance. It uses genome sequencing and bacterial DNA libraries to study pathogens, and develops software and treatments aimed at resistant bacteria. Founded in 2022 by Sam Sihvonen, Timo Moilanen, and Kerkko Visuri, the company is based in Delaware, US. In June 2023, it raised EUR 1 million in seed funding led by Lifeline Ventures, with Wave Ventures, to support product development and commercialization.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in